{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T04:57:12Z","timestamp":1771045032113,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bmc.2022.116966","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T15:17:05Z","timestamp":1660749425000},"page":"116966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Protective immunity triggered by ectonucleoside triphosphate diphosphohydrolase-based biopharmaceuticals attenuates cardiac parasitism and prevents mortality in Trypanosoma cruzi infection"],"prefix":"10.1016","volume":"72","author":[{"given":"Alessandra Teixeira","family":"Paula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla Veloso Gon\u00e7alves","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly Freitas","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Silva Sena","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizi\u00e1ria Cardoso","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00f4mulo Dias","family":"Novaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Almeida","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro Licursi","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.116966_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165658","article-title":"Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control","volume":"1866","author":"Bivona","year":"2020","journal-title":"Biochim Biophys Acta - Mol Basis Dis."},{"key":"10.1016\/j.bmc.2022.116966_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003849","article-title":"Trypanosoma cruzi infection through the oral route promotes a severe infection in mice: new disease form from an old infection?","volume":"9","author":"Barreto-de-Albuquerque","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmc.2022.116966_b0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.semdp.2019.04.008","article-title":"Chagas disease as example of a reemerging parasite","volume":"36","author":"Guarner","year":"2019","journal-title":"Semin Diagnost Pathol."},{"key":"10.1016\/j.bmc.2022.116966_b0020","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","article-title":"Chagas disease","volume":"375","author":"Rassi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2022.116966_b0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/CMR.00005-11","article-title":"Trypanosoma cruzi and Chagas\u2019 disease in the United States","volume":"24","author":"Bern","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmc.2022.116966_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0003540","article-title":"Prevalence of chagas disease in latin-american migrants living in Europe: A systematic review and meta-analysis","volume":"9","author":"Requena-M\u00e9ndez","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2022.116966_b0035","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1128\/AAC.00343-16","article-title":"Curcumin enhances the anti-Trypanosoma cruzi activity of benznidazole-based chemotherapy in acute experimental Chagas disease","volume":"60","author":"Novaes","year":"2016","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"10.1016\/j.bmc.2022.116966_b0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.actatropica.2009.11.003","article-title":"Chagas disease: A Latin American health problem becoming a world health problem","volume":"115","author":"Schmunis","year":"2010","journal-title":"Acta Tropica"},{"key":"10.1016\/j.bmc.2022.116966_b0045","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2022.116966_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002865","article-title":"The global burden of disease study 2010: Interpretation and implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmc.2022.116966_b0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1586\/eri.10.144","article-title":"The urgent need to develop new drugs and tools for the treatment of Chagas disease","volume":"9","author":"Mu\u00f1oz","year":"2011","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.bmc.2022.116966_b0060","doi-asserted-by":"crossref","unstructured":"Diniz L de F, Urbina JA, de Andrade IM, et al. Benznidazole and posaconazole in experimental chagas disease: positive interaction in concomitant and sequential treatments. PLoS Negl Trop Dis 2013;7:e2367.","DOI":"10.1371\/journal.pntd.0002367"},{"key":"10.1016\/j.bmc.2022.116966_b0065","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1128\/AAC.00779-15","article-title":"Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi","volume":"59","author":"Santos","year":"2015","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/j.bmc.2022.116966_b0070","doi-asserted-by":"crossref","unstructured":"Bregano W, Cristina Pica R, Krominski Grac V et al. Phytomonas serpens, a tomato parasite, shares antigens with Trypanosoma cruzi that are recognized by human sera and induce protective immunity in mice, 2003;39:257-64.","DOI":"10.1016\/S0928-8244(03)00256-6"},{"key":"10.1016\/j.bmc.2022.116966_b0075","first-page":"299","article-title":"Protective immunity and pathology induced by inoculation of mice with different subcellular fractions of Trypanosoma cruzi","volume":"42","author":"Ruiz","year":"1985","journal-title":"Acta Tropica"},{"key":"10.1016\/j.bmc.2022.116966_b0080","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.7150\/ijbs.7.1230","article-title":"A DNA vaccine encoding for Tc SSP4 induces protection against acute and chronic infection in experimental chagas disease","volume":"7","author":"Arce-Fonseca","year":"2011","journal-title":"Int J Biol Sci."},{"key":"10.1016\/j.bmc.2022.116966_b0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/pim.12017","article-title":"Differential immune response in mice immunized with the A, R or C domain from TcSP protein of Trypanosoma cruzi or with the coding DNAs","volume":"35","author":"Salgado-Jim\u00e9nez","year":"2013","journal-title":"Parasite Immunology"},{"key":"10.1016\/j.bmc.2022.116966_b0090","doi-asserted-by":"crossref","unstructured":"Dutton JL, Li B, Woo WP et al. A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice. PLoS One 2013;8:2\u201311.","DOI":"10.1371\/journal.pone.0076407"},{"key":"10.1016\/j.bmc.2022.116966_b0095","first-page":"1","article-title":"Prophylactic and therapeutic DNA vaccines against Chagas disease","volume":"8","author":"Arce-Fonseca","year":"2015","journal-title":"Parasites Vect."},{"key":"10.1016\/j.bmc.2022.116966_b0100","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/21645515.2015.1119346","article-title":"A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB\/c mouse model of Chagas disease","volume":"12","author":"Barry","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.bmc.2022.116966_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2019.105168","article-title":"Immunity and vaccine development efforts against Trypanosoma cruzi","volume":"200","author":"Rios","year":"2019","journal-title":"Acta Tropica"},{"key":"10.1016\/j.bmc.2022.116966_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/genes11101196","article-title":"Trypanosoma cruzi genome: Organization, multi-gene families, transcription, and biological implications","volume":"11","author":"Herreros-Cabello","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bmc.2022.116966_b0115","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.3389\/fimmu.2020.595039","article-title":"Experimental nanovaccine offers protection against repeat exposures to Trypanosoma cruzi through activation of polyfunctional T cell response","volume":"11","author":"Chowdhury","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2022.116966_b0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000387","article-title":"Influence of ecto-nucleoside triphosphate diphosphohydrolase activity on Trypanosoma cruzi infectivity and virulence","volume":"3","author":"Santos","year":"2009","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmc.2022.116966_b0125","doi-asserted-by":"crossref","first-page":"12352","DOI":"10.1074\/jbc.273.20.12352","article-title":"Induced activation of the Toxoplasma gondii nucleoside triphosphate hydrolase leads to depletion of host cell ATP levels and rapid exit of intracellular parasites from infected cells","volume":"273","author":"Silverman","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1016\/j.bmc.2022.116966_b0130","doi-asserted-by":"crossref","unstructured":"Sansom FM, Newton HJ, Crikis S, et al. A bacterial ecto-triphosphate diphosphohydrolase similar to human CD39 is essential for intracellular multiplication of Legionella pneumophila, 2007;9:1922\u201335.","DOI":"10.1111\/j.1462-5822.2007.00924.x"},{"key":"10.1016\/j.bmc.2022.116966_b0135","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.4049\/jimmunol.165.8.4704","article-title":"Extracellular ATP and TNF-\u03b1 synergize in the activation and maturation of human dendritic cells","volume":"165","author":"Schnurr","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2022.116966_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.13172\/2052-0069-2-3-1104","article-title":"Implication of purinergic signaling pathways in clinical management of Chagas\u2019 disease","volume":"2","author":"Santos","year":"2013","journal-title":"OA Biotechnol."},{"key":"10.1016\/j.bmc.2022.116966_b0145","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s00436-015-4488-x","article-title":"Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice","volume":"114","author":"Novaes","year":"2015","journal-title":"Parasitol Res"},{"key":"10.1016\/j.bmc.2022.116966_b0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbrc.2004.02.071","article-title":"Characterization and immunolocalization of an NTP diphosphohydrolase of Trypanosoma cruzi","volume":"316","author":"Fietto","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2022.116966_b0155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/AAC.47.1.223-230.2003","article-title":"Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes","volume":"47","author":"De Ornelas Toledo","year":"2003","journal-title":"Antimicrobial Agents Chemotherapy"},{"key":"10.1016\/j.bmc.2022.116966_b0160","first-page":"128p","article-title":"The enzyme linked immunosorbent assay (ELISA): a guide with abstracts of microplate applications","author":"Voller","year":"1979","journal-title":"Dynatech Laboratories"},{"key":"10.1016\/j.bmc.2022.116966_b0165","doi-asserted-by":"crossref","first-page":"18099","DOI":"10.1038\/srep18099","article-title":"Successive site translocating inoculation potentiates DNA\/recombinant vaccinia vaccination","volume":"5","author":"Ren","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.bmc.2022.116966_b0170","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1186\/s12879-017-2834-6","article-title":"Effects of IFN-\u03b3 coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites","volume":"17","author":"P\u00e9rez Brand\u00e1n","year":"2017","journal-title":"BMC Infect Diseases"},{"key":"10.1016\/j.bmc.2022.116966_b0175","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1017\/S0031182016002675","article-title":"Nonsteroidal anti-inflammatory is more effective than anti-oxidant therapy in counteracting oxidative\/nitrosative stress and heart disease in T. cruzi-infected mice","volume":"144","author":"Novaes","year":"2017","journal-title":"Parasitology"},{"key":"10.1016\/j.bmc.2022.116966_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005902","article-title":"Th17 cells are more protective than Th1 cells against the intracellular parasite Trypanosoma cruzi","volume":"12","author":"Cai","year":"2016","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.bmc.2022.116966_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172833","article-title":"The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function","volume":"12","author":"Sousa","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2022.116966_b0190","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/infdis\/jiu480","article-title":"Oral multicomponent DNA vaccine delivered by attenuated Salmonella elicited immunoprotection against American trypanosomiasis","volume":"211","author":"Cazorla","year":"2015","journal-title":"J Infect Diseases"},{"key":"10.1016\/j.bmc.2022.116966_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595039","article-title":"Experimental nanovaccine offers protection against repeat exposures to Trypanosoma cruzi through activation of polyfunctional T cell response","volume":"11","author":"Chowdhury","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2022.116966_b0200","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1016\/j.vaccine.2020.10.006","article-title":"The Trypanosoma cruzi TcTASV-C protein subfamily administrated with U-Omp19 promotes a protective response against a lethal challenge in mice","volume":"38","author":"Caeiro","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.bmc.2022.116966_b0205","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.vaccine.2016.03.074","article-title":"Status of vaccine research and development of vaccines for Chagas disease","volume":"34","author":"Beaumier","year":"2016","journal-title":"Vaccine."},{"key":"10.1016\/j.bmc.2022.116966_b0210","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/erv.12.85","article-title":"Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects","volume":"11","author":"Dumonteil","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.bmc.2022.116966_b0215","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/21645515.2018.1520581","article-title":"Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice","volume":"15","author":"de la Cruz","year":"2019","journal-title":"Hum Vaccin Immunother."},{"key":"10.1016\/j.bmc.2022.116966_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.676183","article-title":"Rapamycin improves the response of effector and memory CD8+ T cells induced by immunization with ASP2 of Trypanosoma cruzi","volume":"11","author":"Moraschi","year":"2021","journal-title":"Front Cellular Infect Microbiol"},{"key":"10.1016\/j.bmc.2022.116966_b0225","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00281-015-0481-9","article-title":"CD8+ T cells in Trypanosoma cruzi infection","volume":"37","author":"Tarleton","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bmc.2022.116966_b0230","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00281-012-0351-7","article-title":"Current Understanding of Immunity to Trypanosoma cruzi Infection and Pathogenesis of Chagas Disease","volume":"34","author":"Machado","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bmc.2022.116966_b0235","article-title":"TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice","volume":"8","author":"Gupta","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2022.116966_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24966\/VRV-0193\/100001","article-title":"Strategy for the development of vaccines against chagas disease","volume":"1","author":"Huang","year":"2015","journal-title":"Vacc Res Vaccin."},{"key":"10.1016\/j.bmc.2022.116966_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2019.01456","article-title":"TcG2\/TcG4 DNA vaccine induces Th1 immunity against acute Trypanosoma cruzi infection: adjuvant and antigenic effects of heterologous T. rangeli booster immunization","volume":"10","author":"Gupta","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2022.116966_b0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0020-7519(01)00322-8","article-title":"Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi","volume":"32","author":"Gao","year":"2002","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.bmc.2022.116966_b0255","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/pim.12183","article-title":"Interleukin-10 and tumour necrosis factor-alpha serum levels in chronic Chagas disease patients","volume":"37","author":"Vasconcelos","year":"2015","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.bmc.2022.116966_b0260","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1128\/iai.63.12.4862-4867.1995","article-title":"Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages","volume":"63","author":"Silva","year":"1995","journal-title":"Infect Immunity"},{"key":"10.1016\/j.bmc.2022.116966_b0265","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.4049\/jimmunol.146.10.3626","article-title":"Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice","volume":"146","author":"Torrico","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2022.116966_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004828","article-title":"A two-component DNA-prime\/protein-boost vaccination strategy for eliciting long-term protective T cell immunity against Trypanosoma cruzi","volume":"11","author":"Gupta","year":"2015","journal-title":"PLOS Pathog."},{"key":"10.1016\/j.bmc.2022.116966_b0275","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1590\/S0074-02762008005000006","article-title":"Importance of TNF-\u03b1 in the course of acute infection with Trypanosoma cruzi: influence of its inhibition by pentoxifylline treatment","volume":"103","author":"Andrade","year":"2008","journal-title":"Memorias do Instituto Oswaldo Cruz"},{"key":"10.1016\/j.bmc.2022.116966_b0280","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.micinf.2007.05.014","article-title":"TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy","volume":"9","author":"Bilate","year":"2007","journal-title":"Microbes Infect"},{"key":"10.1016\/j.bmc.2022.116966_b0285","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-4419-6612-4_23","article-title":"TNF-\u03b1 and TNFR in Chagas disease: from protective immunity to pathogenesis of chronic cardiomyopathy","volume":"691","author":"Lannes-Vieira","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bmc.2022.116966_b0290","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1582-4934.2010.01007.x","article-title":"Chagas\u2019 disease: an update on immune mechanisms and therapeutic strategies","volume":"14","author":"Boscardin","year":"2010","journal-title":"J Cel Mol Medicine"},{"key":"10.1016\/j.bmc.2022.116966_b0295","doi-asserted-by":"crossref","first-page":"ftv082","DOI":"10.1093\/femspd\/ftv082","article-title":"Immunity and immune modulation in Trypanosoma cruzi infection","volume":"73","author":"Cardillo","year":"2015","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.bmc.2022.116966_b0300","article-title":"IL-17, Produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger","volume":"2106\u201312","author":"Ferretti","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2022.116966_b0305","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","article-title":"Interleukin-17 family members and inflammation","volume":"21","author":"Kolls","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.bmc.2022.116966_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001630","article-title":"Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas\u2019 disease","volume":"6","author":"Guedes","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.bmc.2022.116966_b0315","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4049\/jimmunol.0900047","article-title":"IL-17 Is necessary for host protection against acute-phase Trypanosoma cruzi infection","volume":"185","author":"Miyazaki","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.bmc.2022.116966_b0320","doi-asserted-by":"crossref","unstructured":"Magalh\u00e3es LMD, Villani FNA, Nunes M do CP et al. High interleukin 17 Expression is correlated with better cardiac function in human Chagas disease. J Infect Dis 2013;207:661\u2013665.","DOI":"10.1093\/infdis\/jis724"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622003595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622003595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:18:32Z","timestamp":1760836712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622003595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":64,"alternative-id":["S0968089622003595"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116966","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective immunity triggered by ectonucleoside triphosphate diphosphohydrolase-based biopharmaceuticals attenuates cardiac parasitism and prevents mortality in Trypanosoma cruzi infection","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116966"}}